Aug 14, 2026 09:33AM
May 12, 2026 01:33PM
May 11, 2026 04:01PM
Apr 2, 2026 07:01AM
Apr 2, 2026 07:00AM
Mar 10, 2026 04:01PM
Jan 15, 2026 07:05AM Skye Bioscience (SKYE) Reiterated at Neutral by Cantor Fitzgerald
May 8, 2025 04:01PM
Jan 2, 2025 12:51PM
Aug 22, 2024 07:01AM
Aug 22, 2024 07:00AM
Aug 9, 2024 05:59PM
Jul 24, 2024 07:31AM
Jul 24, 2024 07:30AM Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for Obesity
Jul 24, 2024 06:00AM
Jan 29, 2024 08:02AM
Jan 29, 2024 08:00AM
Jan 9, 2024 07:00AM
Dec 11, 2023 07:00AM
Jul 6, 2023 07:00AM
Apr 27, 2023 07:00AM Skye Bioscience Begins Dosing Phase 1 Fourth Cohort in Clinical Trial of Novel CB1R Agonist
Jan 27, 2023 07:00AM
Jan 24, 2023 08:00AM
Dec 20, 2022 07:03AM
Dec 20, 2022 07:00AM
Dec 16, 2022 07:00AM
Nov 17, 2022 07:00AM
Nov 10, 2022 10:48PM Skye Bioscience Closes Acquisition of Emerald Health Therapeutics
Sep 30, 2022 03:24PM
Aug 19, 2022 03:22PM
Aug 19, 2022 02:12PM
Jul 21, 2022 07:00AM
Jul 20, 2022 07:00AM
Jun 30, 2022 07:02AM
Jun 30, 2022 07:00AM Skye Bioscience Receives Australian Ethics Committee Approval to Start First-in-Human Phase 1 Study of SBI-100 Ophthalmic Emulsion
Jan 10, 2022 07:00AM
Apr 22, 2021 08:30AM
Mar 16, 2021 08:30AM

328,876 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All